- Home
- QGEN vs G Comparison
QGEN vs G Comparison
Compare QGEN & G Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QGEN
- G
- Stock Information
- Founded
- QGEN 1986
- G 1997
- Country
- QGEN Netherlands
- G Bermuda
- Employees
- QGEN N/A
- G N/A
- Industry
- QGEN Biotechnology: Biological Products (No Diagnostic Substances)
- G Professional Services
- Sector
- QGEN Health Care
- G Consumer Discretionary
- Exchange
- QGEN Nasdaq
- G Nasdaq
- Market Cap
- QGEN 9.9B
- G 8.2B
- IPO Year
- QGEN 1996
- G 2007
- Fundamental
- Price
- QGEN $39.57
- G $53.23
- Analyst Decision
- QGEN Buy
- G Buy
- Analyst Count
- QGEN 8
- G 9
- Target Price
- QGEN $49.79
- G $46.78
- AVG Volume (30 Days)
- QGEN 1.4M
- G 1.8M
- Earning Date
- QGEN 02-05-2025
- G 02-06-2025
- Dividend Yield
- QGEN 3.34%
- G 1.28%
- EPS Growth
- QGEN N/A
- G N/A
- EPS
- QGEN 0.38
- G 2.85
- Revenue
- QGEN $1,978,214,000.00
- G $4,767,139,000.00
- Revenue This Year
- QGEN $7.22
- G $8.03
- Revenue Next Year
- QGEN $6.74
- G $6.83
- P/E Ratio
- QGEN $103.97
- G $18.68
- Revenue Growth
- QGEN 0.66
- G 6.48
- 52 Week Low
- QGEN $38.49
- G $30.23
- 52 Week High
- QGEN $47.93
- G $56.76
- Technical
- Relative Strength Index (RSI)
- QGEN 34.64
- G 65.11
- Support Level
- QGEN $38.49
- G $54.60
- Resistance Level
- QGEN $40.21
- G $55.84
- Average True Range (ATR)
- QGEN 0.74
- G 1.15
- MACD
- QGEN -0.28
- G 0.00
- Stochastic Oscillator
- QGEN 18.91
- G 60.73
About QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2023 sales), followed by EMEA (32%), and the Asia-Pacific (16%).
About G Genpact Limited
Genpact Ltd is a provider of business process management services. Clients are industry verticals and operate in banking and financial services, insurance, capital markets, consumer product goods, life sciences, infrastructure, manufacturing and services, healthcare, and high-tech. Genpact's services include aftermarket, direct procurement, risk and compliance, human resources, IT, industrial solutions, collections, finance and accounting, and media services. Genpact's end market by revenue is India. It is a General Electric spin-off, which is still a large source of revenue for Genpact.